Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
White House unveils  billion biotech spending plan ahead of industry summit

White House unveils $2 billion biotech spending plan ahead of industry summit

by admin | Oct 8, 2022 | News & Opinions

By Jarrett Renshaw – Reuters The White House released new details on Wednesday on how it plans to invest more than $2 billion in the U.S. biotechnology sector as it hosts a meeting of government leaders to discuss the emerging industry. President Joe Biden on...
CIRM awards UCI $2.7 million to create regenerative medicine training program

CIRM awards UCI $2.7 million to create regenerative medicine training program

by admin | Oct 7, 2022 | News & Opinions

Brian Cummings, UCI professor of physical medicine & rehabilitation and founding member of the Sue & Bill Gross Stem Cell Research Center, has received a five-year, $2.7 million grant from the California Institute for Regenerative Medicine to establish a...
Common Viruses May Be Triggering the Onset of Alzheimer’s Disease

Common Viruses May Be Triggering the Onset of Alzheimer’s Disease

by admin | Sep 21, 2022 | News & Opinions

Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain by Mike Silver  – TuftsNow Alzheimer’s disease can begin almost imperceptibly, often masquerading in the...
After last year’s public rejection, BrainStorm to give ALS cell therapy another shot

After last year’s public rejection, BrainStorm to give ALS cell therapy another shot

by admin | Sep 20, 2022 | News & Opinions

by Tyler Patchen and Kyle LaHucik – EndpointsNews Above image caption:  Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to...
A research partnership brings gene editing promise to eye disease

A research partnership brings gene editing promise to eye disease

by admin | Sep 19, 2022 | News & Opinions

by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...
Page 162 of 170« First«161162163»Last »

Recent Posts

  • Scientists Unveil Breakthrough Method to Mass-Produce Cancer-Fighting Natural Killer Cells
  • Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
  • Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
  • Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
  • Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells
Tweets about @WSCSummit